Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

This grant supports biologic-based therapeutic discovery and development for nervous system disorders, covering preclinical work through phase I clinical testing. It funds large biologic macromolecules, gene-based therapies, cell therapies, and emerging approaches such as microbial and microbiome therapies, with collaboration and optional CRO support.